UTHR: Wutah pendapatan triwulanan United Therapeutics

United Therapeutics (UTHR) - logo korporat

United Therapeutics is scaling drug production through a pool of external partners to avoid reliance on a single supplier. The quarterly revenue growth history visualizes this trend, where 4.20 captures the magnitude of this parameter. Business stability is based on its own substance synthesis plants, while success relies on FDA approval and patent protection for new therapy methods.

UTHR Tambahing pendapatan triwulanan United Therapeutics Corp. (04.07.2022 - 20.11.2026)

Ringkesan rincian data analitis United Therapeutics Corp. (UTHR)

- rega saham lan target rega konsensus:
- indikator dhuwit lan arus kas:
Analisis kabeh metrik perusahaan:UTHR - United Therapeutics Corporation
Produk sing diprodhuksi United Therapeutics Corp

To select fundamental leaders within the biotech sector, the analyst evaluates operating income dynamics. This metric measures quarterly revenue expansion rates, revealing hidden momentum loss or accelerated business expansion. For United Therapeutics (UTHR), this growth confirms the commercial efficiency of its patent portfolio and the success of its drug delivery systems. By analyzing the quarterly revenue growth trend, an investor can determine the company's stability on its path toward a bioprinting monopoly.

Pesaing langsung

Vertex Pharmaceuticals - Wutah pendapatan triwulanan|Tambahing pendapatan triwulanan ALNY (Alnylam Pharmaceuticals)|INSM: Wutah pendapatan triwulanan|BioMarin Pharmaceutical Inc. (BMRN) - Wutah pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal BridgeBio Pharma Inc|Wutah dodolan triwulanan BGM Group Ltd (BGM)|Wutah pendapatan kuartal marang kuartal cogentbio.com (COGT)|Wutah dodolan triwulanan Xeris Biopharma XERS|Wutah pendapatan triwulanan KROS (kerostx.com)|Wutah pendapatan triwulanan Arcturus Therapeutics Holdings Inc. ARCT|etonpharma.com - Wutah pendapatan triwulanan|KMDA - Wutah pendapatan triwulanan|FULC (Fulcrum Corp) - Wutah dodolan triwulanan|ABEO (Abeona Therapeutics, Inc.) - Wutah pendapatan kuartal marang kuartal|Wutah pendapatan kuartal marang kuartal mereobiopharma.com|PLX (Protalix BioTherapeutics, Inc.) - Owah-owahan dodolan kuartal marang kuartal|Wutah pendapatan triwulanan PLRX|Wutah pendapatan kuartal marang kuartal APLT (Applied Therapeutics)|Rein Therapeutics Inc - Wutah dodolan triwulanan|Gelteq Limited (GELS) - Tingkat wutah pendapatan sajrone kuartal|aytubio.com - Wutah pendapatan triwulanan|chemomab.com (CMMB) - Wutah dodolan triwulanan|SRXH: Wutah pendapatan triwulanan|Dinamika pendapatan kuartal marang kuartal PLRZ (Polyrizon Ltd.)|Wutah dodolan triwulanan AEZS|CYTH: Tambahing pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal inozyme.com (INZY)|Wutah pendapatan triwulanan Reneo Pharmaceuticals Inc. (RPHM)|Wutah pendapatan triwulanan CSCI (Aeterna Zentaris)